$19.08 1.5%
Price vs. AI Score (Last 150 days)
Data gathered: December 6

Data Bits

Data Bits Value / Change Benchmark
Job Posts 4 0%
Sentiment 100 0%
Webpage traffic 14,000 84.5%
Employee Rating 68 0%
Google Adspend $4,529 -56.8% N/A
Google Trends -100%
Linkedin Employees 98 N/A
Patents 9 0%
4chan Mentions 0% N/A
Facebook Engagement 100 -1%
Facebook followers 145 0%
Stocktwits Mentions 24 -54.7%
Stocktwits Subscribers 684 1.3%
Twitter Followers 13,209 -0%
Youtube Subscribers 58 1.8%
Instagram Followers 5,245 -0.1%
News Mentions 0%
Reddit Mentions -100%
Business outlook 65 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Biomea Fusion

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.

Biomea Fusion
Price $19.08
Target Price Sign up
Market Cap $596M
Dividend Yield 0
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2305.8M-5.8M-28M-31M
Q2 '2305.7M-5.7M-25M-28M
Q1 '2305.6M-5.6M-29M-30M
Q4 '2205.7M-5.7M-25M-26M
Q3 '22165M5.2M-5.2M-23M-23M

Insider Transactions

A2A Pharmaceuticals, Inc. filed to sell 3,500,000 shares at $34.6.
June 2 '23
A2A Pharmaceuticals, Inc. filed to sell 3,625,000 shares at $33.8.
May 17 '23
A2A Pharmaceuticals, Inc. filed to sell 3,650,000 shares at $34.5.
May 10 '23
A2A Pharmaceuticals, Inc. filed to sell 3,900,000 shares at $29.1.
April 26 '23
A2A Pharmaceuticals, Inc. filed to sell 4,100,000 shares at $31.3.
April 6 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.